| First Author | Besedovsky HO | Year | 2000 |
| Journal | Int J Cancer | Volume | 86 |
| Issue | 4 | Pages | 457-61 |
| PubMed ID | 10797255 | Mgi Jnum | J:61803 |
| Mgi Id | MGI:1355605 | Doi | 10.1002/(sici)1097-0215(20000515)86:4<457::aid-ijc2>3.0.co;2-0 |
| Citation | Besedovsky HO, et al. (2000) Endocrine host responses during early and late phases of tumor development. Int J Cancer 86(4):457-61 |
| abstractText | It is well established that hormones affect tumor growth. Conversely, inoculation of cells obtained from tumors that had been transplanted for many generations causes changes in the concentration of different hormones before and after tumor detection. We aimed at answering the question of whether hormonal alterations also occur during the development of primary tumors and following transplantation of tumors from early generations. Primary tumors were induced in mice by either the carcinogenic agent 3-methylcholanthrene, which produces fibrosarcomas, or the milk-transmitted mammary tumor virus, which induces adenocarcinomas. The results showed that (i) in both models, an early reduction in plasma insulin and prolactin levels occurred, and in the case of insulin, this reduction was sustained for a prolong period prior to tumor detection, indicating that recognition by the host of emergent tumor cells triggers an endocrine response; (ii) in contrast with multiply transplanted tumors, cells from early transplant generations produced no significant endocrine changes during latency; (iii) irrespective of whether they were primary or transplanted, large tumor burdens caused similar hormonal alterations, consisting of increased corticosterone and growth hormone and decreased insulin, thyroxin, prolactin and sex steroid levels in blood. Our comprehensive longitudinal study demonstrates host endocrine responses during different stages of neoplastic development. Copyright 2000 Wiley-Liss, Inc. |
